Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine during sedated cataract surgery
IRCT20180416039326N26Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Oxygen saturation, Occurrence of oxygen desaturation and 7 more. Started Jul 2026; status: recruiting.
02
Drugs
lidocaine
Beyond the preview
Go deeper on IRCT20180416039326N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N26.